ASCLEPIX THERAPEUTICS Trademark

Trademark Overview

On Tuesday, June 2, 2020, a trademark application was filed for ASCLEPIX THERAPEUTICS with the United States Patent and Trademark Office. The USPTO has given the ASCLEPIX THERAPEUTICS trademark a serial number of 88944666. The federal status of this trademark filing is REGISTERED as of Tuesday, July 2, 2024. This trademark is owned by AsclepiX Therapeutics, Inc.. The ASCLEPIX THERAPEUTICS trademark is filed in the Pharmaceutical Products category with the following description:

Therapeutic pharmaceutical for the treatment of retinal diseases; ocular pharmaceuticals
asclepix therapeutics

General Information

Serial Number88944666
Word MarkASCLEPIX THERAPEUTICS
Filing DateTuesday, June 2, 2020
Status700 - REGISTERED
Status DateTuesday, July 2, 2024
Registration Number7434276
Registration DateTuesday, July 2, 2024
Mark Drawing4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form
Published for Opposition DateTuesday, March 9, 2021

Trademark Statements

Goods and ServicesTherapeutic pharmaceutical for the treatment of retinal diseases; ocular pharmaceuticals
NOT AVAILABLE"THERAPEUTICS"

Classification Information

International Class005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides.
US Class Codes005, 006, 018, 044, 046, 051, 052
Class Status Code6 - Active
Class Status DateWednesday, June 24, 2020
Primary Code005
First Use Anywhere DateThursday, November 30, 2023
First Use In Commerce DateThursday, November 30, 2023

Trademark Owner History

Party NameAsclepiX Therapeutics, Inc.
Party Type30 - Original Registrant
Legal Entity Type03 - Corporation
AddressBethesda, MD 20816
Party NameAsclepiX Therapeutics, Inc.
Party Type20 - Owner at Publication
Legal Entity Type03 - Corporation
AddressBethesda, MD 20816
Party NameAsclepiX Therapeutics, Inc.
Party Type10 - Original Applicant
Legal Entity Type03 - Corporation
AddressJersey City, NJ 07311

Trademark Events

Event DateEvent Description
Friday, June 5, 2020NEW APPLICATION ENTERED
Thursday, September 3, 2020NON-FINAL ACTION WRITTEN
Wednesday, June 24, 2020NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Wednesday, September 2, 2020ASSIGNED TO EXAMINER
Thursday, September 3, 2020NON-FINAL ACTION E-MAILED
Thursday, September 3, 2020NOTIFICATION OF NON-FINAL ACTION E-MAILED
Friday, January 22, 2021CORRESPONDENCE RECEIVED IN LAW OFFICE
Wednesday, October 7, 2020TEAS RESPONSE TO OFFICE ACTION RECEIVED
Wednesday, January 20, 2021ASSIGNED TO LIE
Friday, January 22, 2021TEAS/EMAIL CORRESPONDENCE ENTERED
Wednesday, February 17, 2021NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED
Monday, February 1, 2021APPROVED FOR PUB - PRINCIPAL REGISTER
Tuesday, March 9, 2021PUBLISHED FOR OPPOSITION
Tuesday, March 9, 2021OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
Tuesday, May 4, 2021NOA E-MAILED - SOU REQUIRED FROM APPLICANT
Friday, November 5, 2021NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, November 3, 2021SOU TEAS EXTENSION RECEIVED
Wednesday, November 3, 2021SOU EXTENSION 1 FILED
Wednesday, November 3, 2021SOU EXTENSION 1 GRANTED
Tuesday, October 25, 2022SOU EXTENSION 3 FILED
Wednesday, May 4, 2022SOU TEAS EXTENSION RECEIVED
Wednesday, May 4, 2022SOU EXTENSION 2 FILED
Wednesday, May 4, 2022SOU EXTENSION 2 GRANTED
Friday, May 6, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Tuesday, October 25, 2022SOU TEAS EXTENSION RECEIVED
Tuesday, October 25, 2022SOU EXTENSION 3 GRANTED
Wednesday, October 11, 2023SOU EXTENSION 5 GRANTED
Thursday, October 27, 2022NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Thursday, April 27, 2023SOU TEAS EXTENSION RECEIVED
Thursday, April 27, 2023SOU EXTENSION 4 FILED
Thursday, April 27, 2023SOU EXTENSION 4 GRANTED
Saturday, April 29, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Monday, October 2, 2023SOU TEAS EXTENSION RECEIVED
Monday, October 2, 2023SOU EXTENSION 5 FILED
Wednesday, October 11, 2023CASE ASSIGNED TO INTENT TO USE PARALEGAL
Thursday, October 12, 2023NOTICE OF APPROVAL OF EXTENSION REQUEST E-MAILED
Wednesday, May 1, 2024USE AMENDMENT FILED
Wednesday, May 1, 2024TEAS STATEMENT OF USE RECEIVED
Thursday, May 2, 2024STATEMENT OF USE PROCESSING COMPLETE
Tuesday, May 28, 2024NOTICE OF ACCEPTANCE OF STATEMENT OF USE E-MAILED
Tuesday, May 28, 2024ALLOWED PRINCIPAL REGISTER - SOU ACCEPTED
Tuesday, July 2, 2024REGISTERED-PRINCIPAL REGISTER
Tuesday, July 2, 2024NOTICE OF REGISTRATION CONFIRMATION EMAILED

Related Keywords

therapeutics asclepix ocular pharmaceuticals diseases retinal pharmaceutical treatment therapeutic